biomea fusion
Sujatha Kalle has extensive experience in clinical research coordination, working with various medical institutions such as Stanford University School of Medicine and Biomea Fusion. Sujatha has managed multiple research studies in areas such as interventional cardiology and acute stroke trials. Sujatha's background includes volunteer work at Palo Alto VA Hospital and California Pacific Medical Center, focusing on medical oncology and transplant nephrology. Sujatha holds a Bachelor of Medicine, Bachelor of Surgery degree from Sri Venkateswara University and continues to expand their knowledge in Clinical Trials Design and Management at UCSC Silicon Valley Extension.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.